Table 1 Clinical characteristics of incident hemodialysis patients by consequences of vascular access preparation.
VA created timely (n = 676) | VA created not timely (n = 87) | VA not created (n = 224) | |
|---|---|---|---|
Male sex n (%) | 367 (54.3) | 38 (43.7) | 113 (50.4) |
Age at CKD program enrollment (year) | 62.6 ± 11.7 | 63.7 ± 12.4 | 64.1 ± 13.1 |
Age at VA creation (year) | 65.5 ± 11.8 | 66.0 ± 12.0 | 66.3 ± 13.4 |
Age at first HD (year) | 65.0 ± 11.7 | 65.8 ± 11.9 | 66.6 ± 13.4 |
Marital status n (%) | |||
Unmarried | 40 (5.9) | 5 (5.7) | 15 (6.7) |
Married | 536 (79.3) | 62 (71.3) | 167 (74.6) |
Other | 100 (14.8) | 20 (23) | 42 (18.8) |
Year of education n (%) | |||
≤ 6 | 343 (50.7) | 43 (49.4) | 117 (52.2) |
7–12 | 241 (35.7) | 35 (40.2) | 74 (33) |
≥ 13 | 92 (13.6) | 9 (10.3) | 33 (14.7) |
Occupation n (%) | |||
No | 336 (49.7) | 39 (44.8) | 120 (53.6) |
Yes | 235 (34.8) | 31 (35.6) | 76 (33.9) |
Retirement | 105 (15.5) | 17 (19.5) | 28 (12.5) |
Smoke n (%) | |||
No | 546 (80.8) | 75 (86.2) | 186 (83) |
Yes | 130 (19.2) | 12 (13.8) | 38 (17) |
Primary disease n (%) | |||
CGN | 184 (27.2) | 21 (24.1) | 44 (19.6) |
DM | 328 (48.5) | 46 (52.9) | 124 (55.4) |
HTN | 69 (10.2) | 6 (6.9) | 23 (10.3) |
Other | 95 (14.1) | 14 (16.1) | 33 (14.7) |
CKD progression | |||
eGFR slope (ml/min/1.73 m2 per year)a | − 4.3 (− 7.4, − 2.4) | − 5.4 (− 10.0, − 2.6) | − 5.7 (− 11.0, − 3.3) |
VA type (missing n = 13)# n (%)a | |||
AVF | 576 (85.2) | 74 (85.1) | 159 (75.4) |
AVG | 100 (14.8) | 13 (14.9) | 42 (19.9) |
Permanent catheter | 0 | 0 | 10 (4.7) |
VA used at first dialysis n (%)a,b | |||
Shunt | 676 (100) | 0 | 0 |
Catheter | 0 | 87 (100) | 220 (98.2) |
Permanent catheter | 0 | 0 | 4 (1.8) |
VA created > 1 time before first HD n (%) | 9 (1.3) | 1 (1.1) | 0 |
Renal function at multidisciplinary CKD care program enrollment | |||
Cr (mg/dL) | 3.8 (2.8, 5.5) | 3.8 (2.7, 6.2) | 3.5 (2.4, 4.9) |
eGFR (MDRD) (ml/min/1.73 m2) | 14.3 (9.3, 22.6) | 14.3 (9.2, 24) | 16.0 (10.9, 24.9) |
eGFR (CG) (ml/min/1.73 m2) | 15.5 (10.6, 24.2) | 15.3 (9.4, 24.6) | 17.6 (11.1, 27.5) |
Renal function at VA creation | |||
Cr (mg/dL)b | 8.5 (7.2, 10.3) | 9.4 (7.4, 11.8) | – |
eGFR (MDRD) (ml/min/1.73 m2)b | 5.9 (4.8, 7.2) | 5.0 (3.9, 6.7) | – |
eGFR (CG) (ml/min/1.73 m2)b | 6.8 (5.5, 8.4) | 6.1 (4.5, 7.4) | – |
Renal function at first HD | |||
Cr (mg/dL)a | 11.2 (8.9, 13.7) | 11.8 (9.3, 14.6) | 10.6 (8, 13.3) |
eGFR (MDRD) (ml/min/1.73 m2)a,b | 4.3 (3.4, 5.5) | 3.9 (3.3, 5.0) | 4.6 (3.5, 5.9) |
eGFR (CG) (ml/min/1.73 m2)a,b | 5.2 (4.1, 6.8) | 4.8 (3.9, 6.4) | 5.6 (4.3, 7.4) |
Multidisciplinary CKD care program duration (days)a,b | 737 (417, 1440) | 601 (325, 959) | 509 (311, 1093) |
Time between VA creation and first HD (days)b | 105 (51, 226) | 14 (6, 27) | – |